Serum phosphorus management with sucroferric oxyhydroxide as a first-line phosphate binder within the first year of hemodialysis
CONCLUSIONS: Among patients on hemodialysis, initiating SO as a first-line PB resulted in significant reductions in sP while maintaining a relatively low PB pill burden.PMID:38091973 | DOI:10.1159/000535754
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Juan A Medaura Meijiao Zhou Linda H Ficociello Michael S Anger Stuart M Sprague Source Type: research
More News: Calcium | Dialysis | Hemodialysis | Hormones | Iron | Laboratory Medicine | Phosphorus | Study | Urology & Nephrology